These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 4083212

  • 1. [Histopathologic evaluation of anti-tumor activity of alpha-interferon for renal cell carcinoma, especially in autoptic cases].
    Yamauchi T, Kawamura J, Yoshida O, Fukuyama T, Ogura K, Nakagawa K.
    Hinyokika Kiyo; 1985 Sep; 31(9):1539-52. PubMed ID: 4083212
    [Abstract] [Full Text] [Related]

  • 2. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
    Rinehart J, Malspeis L, Young D, Neidhart J.
    Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
    Kempf RA, Grunberg SM, Daniels JR, Skinner DG, Venturi CL, Spiegel R, Neri R, Greiner JM, Rudnick S, Mitchell MS.
    J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
    [Abstract] [Full Text] [Related]

  • 7. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R, Scheithauer W, Ludwig H, Flener R.
    Acta Med Austriaca; 1985 Feb; 12(5):129-34. PubMed ID: 3938590
    [Abstract] [Full Text] [Related]

  • 8. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
    Maruoka M, Fujimura M, Kawamura K, Suzuki S, Hamano M, Nishikawa Y, Nagayama T.
    Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
    [Abstract] [Full Text] [Related]

  • 9. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
    Elsässer-Beile U, Kölble N, Grussenmeyer T, Wetterauer U, Schultze-Seemann W.
    Anticancer Res; 1998 May; 18(3B):1883-90. PubMed ID: 9677439
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors].
    Niijima T, Akaza H, Koyanagi T, Togashi M, Kumamoto Y, Funyu T, Suzuki T, Orikasa S, Yoshikawa K, Koiso K.
    Hinyokika Kiyo; 1992 Oct; 38(10):1201-7. PubMed ID: 1481783
    [Abstract] [Full Text] [Related]

  • 14. [Phase II study of recombinant human leukocyte A interferon on urogenital cancer patients].
    Yoshimoto J, Tsushima T, Matsumura Y, Ohmori H, Saito N, Tanaka H, Asahi T, Ohkita K, Tanahashi T, Nanba K.
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):465-70. PubMed ID: 4004282
    [Abstract] [Full Text] [Related]

  • 15. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
    Kawamura J, Yamauchi T, Hashimura T, Yoshida O, Kohnami T, Tomoyoshi T, Ogura K, Fukuyama T, Nakagawa K.
    Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
    [Abstract] [Full Text] [Related]

  • 16. [Effect of recombinant alpha-interferon on advanced renal cell carcinoma].
    Isaka S, Okano T, Akimoto S, Shimazaki J, Murakami S, Igarashi T, Kitamura Y, Yamaguchi K, Kataumi S, Ohtsuka K.
    Hinyokika Kiyo; 1985 Dec; 31(12):2209-14. PubMed ID: 3832921
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M.
    Urol Oncol; 2009 Dec; 27(6):598-603. PubMed ID: 18818106
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies.
    Baisch H, Otto U, Klöppel G.
    Cancer Res; 1990 Oct 01; 50(19):6389-95. PubMed ID: 2400997
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of advanced renal cell carcinoma with subcutaneous administration of interleukin 2 and interferon-alpha].
    Hofmockel G, Theiss M, Bussen D, Wirth MP, Frohmüller HG.
    Urologe A; 1994 Sep 01; 33(5):434-9. PubMed ID: 7974933
    [Abstract] [Full Text] [Related]

  • 20. [In vivo anti-tumour efficacy of tumour necrosis factor and interferon- alpha, -gamma on human renal cell carcinoma heterotransplanted in nude mice].
    Onishi T, Machida T, Masuda F, Iizuka N, Nakauchi K, Furuta N, Shirakawa H.
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug 20; 25(8):1571-8. PubMed ID: 2121869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.